Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SJP-0154 Phase 2 randomized trial in dry eye disease
jRCT2031240009Phase 2Completed
- Sponsor
- Senju Pharmaceutical Co., Ltd.
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dry eye syndrome (DED) comparing SJP-0154 with Placebo (2 arms). Started Apr 2024; status: completed.
02
Drugs
repaglinide
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT2031240009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240009.